Psyence BioMed Chief of Global Impact to speak at Psychedelic Science 2025
Psyence BioMed’s Chief of Global Impact, Mary-Elizabeth Gifford, joins PS2025’s Business Track as a featured speaker at the world’s top psychedelic science event.
Psyence Group2025-06-18T14:37:22+02:00June 18, 2025|Investor Information, Press Releases, Psychedelic News|
Psyence BioMed’s Chief of Global Impact, Mary-Elizabeth Gifford, joins PS2025’s Business Track as a featured speaker at the world’s top psychedelic science event.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |